These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 23438357)
1. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357 [TBL] [Abstract][Full Text] [Related]
2. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer]. You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970 [TBL] [Abstract][Full Text] [Related]
3. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer. Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434 [TBL] [Abstract][Full Text] [Related]
4. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma. Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963 [TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735 [TBL] [Abstract][Full Text] [Related]
6. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results. Hoppe BS; Flampouri S; Henderson RH; Pham D; Bajwa AA; D'Agostino H; Huh SN; Li Z; Mendenhall NP; Nichols RC Clin Lung Cancer; 2012 Sep; 13(5):352-8. PubMed ID: 22264659 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study. Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169 [TBL] [Abstract][Full Text] [Related]
8. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer. Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345 [TBL] [Abstract][Full Text] [Related]
10. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Nichols RC; George TJ; Zaiden RA; Awad ZT; Asbun HJ; Huh S; Ho MW; Mendenhall NP; Morris CG; Hoppe BS Acta Oncol; 2013 Apr; 52(3):498-505. PubMed ID: 23477361 [TBL] [Abstract][Full Text] [Related]
11. Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial. Sheikh H; Colaco R; Lorigan P; Blackhall F; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C Lung Cancer; 2011 Oct; 74(1):75-9. PubMed ID: 21353720 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of risk factors of radiation-induced toxicity in limited-stage small cell lung cancer treated with hypofractionated intensity-modulated radiotherapy]. Zhao JJ; Bi N; Zhang T; Wang JY; Deng L; Wang X; Chen DF; Dai JR; Wang LH Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):627-633. PubMed ID: 37462020 [No Abstract] [Full Text] [Related]
13. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536 [TBL] [Abstract][Full Text] [Related]
14. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin. Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung]. Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy]. Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities. Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386 [TBL] [Abstract][Full Text] [Related]
20. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer. Sas-Korczynska B; Sokolowski A; Korzeniowski S Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]